Science Corp wins EU CE mark for PRIMA retinal implant

Approval under the EU Medical Device Regulation clears commercialization in more than 30 European countries after positive PRIMAvera trial results published in the New England Journal of Medicine.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.